Nivolumab is a fully human IgG4 monoclonal antibody that targets the programmed death-1 (PD-1) receptor. By modulating immune checkpoints, nivolumab […]
Nivolumab (Opdivo®): An Evidence-Based Overview (2025) Read More »
Cabozantinib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of several advanced and metastatic cancers. It inhibits
Cabozantinib (Cabometyx®, Cometriq®): A 2025 Clinical Overview Read More »
What is Ipilimumab? Ipilimumab is a humanized monoclonal antibody that targets CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), a key immune checkpoint
Ipilimumab – Indications, Dosage, and Side Effects Read More »
